Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 7;22(2):521.
doi: 10.3390/ijms22020521.

Nitric Oxide and S-Nitrosylation in Cardiac Regulation: G Protein-Coupled Receptor Kinase-2 and β-Arrestins as Targets

Gizem Kayki-Mutlu  1   2 , Walter J Koch  1
Affiliations
Review

Nitric Oxide and S-Nitrosylation in Cardiac Regulation: G Protein-Coupled Receptor Kinase-2 and β-Arrestins as Targets

Gizem Kayki-Mutlu et al. Int J Mol Sci. .

Abstract

Cardiac diseases including heart failure (HF), are the leading cause of morbidity and mortality globally. Among the prominent characteristics of HF is the loss of β-adrenoceptor (AR)-mediated inotropic reserve. This is primarily due to the derangements in myocardial regulatory signaling proteins, G protein-coupled receptor (GPCR) kinases (GRKs) and β-arrestins (β-Arr) that modulate β-AR signal termination via receptor desensitization and downregulation. GRK2 and β-Arr2 activities are elevated in the heart after injury/stress and participate in HF through receptor inactivation. These GPCR regulators are modulated profoundly by nitric oxide (NO) produced by NO synthase (NOS) enzymes through S-nitrosylation due to receptor-coupled NO generation. S-nitrosylation, which is NO-mediated modification of protein cysteine residues to generate an S-nitrosothiol (SNO), mediates many effects of NO independently from its canonical guanylyl cyclase/cGMP/protein kinase G signaling. Herein, we review the knowledge on the NO system in the heart and S-nitrosylation-dependent modifications of myocardial GPCR signaling components GRKs and β-Arrs.

Keywords: GRK2; S-nitrosylation; nitric oxide; β-arrestins.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation depicting the current understanding of the interaction between β-AR-signaling and GRK2 S-nitrosylation. β-AR, β-adrenergic receptor; G-protein subtypes (Gs or Gi); GRK2, G protein-coupled receptor kinase 2; NO, nitric oxide; eNOS, endothelial nitric oxide synthase; nNOS, neuronal nitric oxide synthase. Green arrow is used to indicate a stimulatory mechanism involved while red bar-headed line indicates an inhibitory mechanism.
Figure 2
Figure 2
Differential regulation of GRK subtypes via S-nitrosylation. GRK, G protein-coupled receptor kinase; NO, nitric oxide; eNOS, endothelial nitric oxide synthase; nNOS, neuronal nitric oxide synthase. Green arrow is used to indicate a stimulatory mechanism involved.
Figure 3
Figure 3
Differential regulation of β-arrestins via S-nitrosylation. β-Arr, β-arrestin; NO, nitric oxide; eNOS, endothelial nitric oxide synthase; nNOS, neuronal nitric oxide synthase; iNOS, inhibitory nitric oxide synthase. Green arrow is used to indicate a stimulatory mechanism involved.
See this image and copyright information in PMC

References

    1. Pfleger J., Gresham K., Koch W.J. G protein-coupled receptor kinases as therapeutic targets in the heart. Nat. Rev. Cardiol. 2019;16:612–622. doi: 10.1038/s41569-019-0220-3. - DOI - PubMed
    1. Wang J., Gareri C., Rockman H.A. G-Protein–Coupled Receptors in Heart Disease. Circ. Res. 2018;123:716–735. doi: 10.1161/CIRCRESAHA.118.311403. - DOI - PMC - PubMed
    1. De Lucia C., Eguchi A., Koch W.J. New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging. Front. Pharmacol. 2018;9:904. doi: 10.3389/fphar.2018.00904. - DOI - PMC - PubMed
    1. Grisanti L.A., Schumacher S.M., Tilley D.G., Koch W.J. Designer Approaches for G Protein–Coupled Receptor Modulation for Cardiovascular Disease. JACC Basic Transl. Sci. 2018;3:550–562. doi: 10.1016/j.jacbts.2017.12.002. - DOI - PMC - PubMed
    1. Sato P.Y., Chuprun J.K., Schwartz M., Koch W.J. The Evolving Impact of G Protein-Coupled Receptor Kinases in Cardiac Health and Disease. Physiol. Rev. 2015;95:377–404. doi: 10.1152/physrev.00015.2014. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources